Method for treating heart failure with stresscopin-like peptides

Details for Australian Patent Application No. 2010315131 (hide)

Owner Janssen Pharmaceutica NV

Inventors Gengo, Peter J.; Sabbah, Hani N.; Shankley, Nigel P.

Agent Shelston IP

Pub. Number AU-A-2010315131

PCT Pub. Number WO2011/057027

Priority 12/612,548 04.11.09 US; 61/258,181 04.11.09 US

Filing date 4 November 2010

Wipo publication date 12 May 2011

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/057027 Priority application(s): WO2011/057027

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010315132-Devices and methods for modulating brain activity

2010315128-System for supply chain management